The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen‐related receptor α protein

JL Fiori(National Institutes of Health), Michel Bernier(Diabetes Australia)
British Journal of Pharmacology
March 30, 2011
Cited by 24


Related Papers